Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Apyx Medical Corp (NQ: APYX )

3.070 -0.080 (-2.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 159,048
Open 3.210
Bid (Size) 3.000 (3)
Ask (Size) 4.920 (2)
Prev. Close 3.150
Today's Range 3.050 - 3.230
52wk Range 1.310 - 7.970
Shares Outstanding 34,322,749
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Amyris, Inc. (NASDAQ: AMRS) shares jumped 179.1% to $0.1839. Amyris shares dipped over 80% on Thursday after the company announced it filed for Chapter 11 bankruptcy. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga

Performance

YTD
+21.83%
+21.83%
1 Month
-29.59%
-29.59%
3 Month
-59.07%
-59.07%
6 Month
+10.83%
+10.83%
1 Year
-34.40%
-34.40%

More News

Read More
Apyx Medical Corp. (NASDAQ: APYX) Leading the Way in Friday Trading Based on Percentage Gain
Via Investor Brand Network
Apyx Medical: Q1 Earnings Insights
Via Benzinga
Apyx Medical Earnings Perspective: Return On Invested Capital
Via Benzinga
Earnings Preview For Apyx Medical
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
Via Benzinga
Why Cineverse Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2023 Financial Results on August 10, 2023
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece
From Apyx Medical Corporation
Via Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Apyx Medical Corporation Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2022 Financial Results; Introduces Full Year 2023 Financial Outlook
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Coagulate and Contract Soft Tissues, Including Subcutaneous Tissue, Where Needed
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Announces New Five-Year Credit Agreement with MidCap Financial
From Apyx Medical Corporation
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2022 Financial Results on March 16, 2023
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Announces FDA 510(k) Submission for the Use of the Renuvion® APR Handpiece for the Coagulation of Subcutaneous Soft Tissues Where Needed, Following Liposuction
From Apyx Medical Corporation
Via Business Wire
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results
From Apyx Medical Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.